1. Home
  2. MAMA vs RGNX Comparison

MAMA vs RGNX Comparison

Compare MAMA & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mama's Creations Inc.

MAMA

Mama's Creations Inc.

N/A

Current Price

$11.13

Market Cap

602.1M

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.17

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MAMA
RGNX
Founded
2010
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
602.1M
487.2M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
MAMA
RGNX
Price
$11.13
$7.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
11
Target Price
★ $21.88
$21.40
AVG Volume (30 Days)
578.2K
★ 1.1M
Earning Date
12-07-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 44.44
18.08
EPS
★ 0.10
N/A
Revenue
★ $95,420,129.00
$10,393,000.00
Revenue This Year
$30.53
N/A
Revenue Next Year
$12.40
$24.01
P/E Ratio
$112.23
★ N/A
Revenue Growth
95.54
★ 126.48
52 Week Low
$10.24
$5.46
52 Week High
$21.00
$16.19

Technical Indicators

Market Signals
Indicator
MAMA
RGNX
Relative Strength Index (RSI) 31.17 45.79
Support Level N/A $6.79
Resistance Level $13.75 $7.32
Average True Range (ATR) 0.65 0.59
MACD -0.21 -0.03
Stochastic Oscillator 9.84 19.32

Price Performance

Historical Comparison
MAMA
RGNX

About MAMA Mama's Creations Inc.

Mama's Creations Inc manufactures and markets fresh deli-prepared foods distributed through grocery, mass, club, and convenience stores across the United States. Its product portfolio includes refrigerated prepared foods such as meatballs, meatloaf, sausage products, and pasta and rice entrees. The products are principally sold to supermarkets, club chains, mass-market retailers, and food distributors. The brand of the company includes Mama's Creations, Mama's Mancini's, The Olive Branch, Creative Salads, and others.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: